ASEBIO 2006 REPORTExecutive Summary

1.

Executive Summary1.

According to ASEBIO estimation, over 500 enterprises undertook biotech activities in Spain in 2006, producing a turnover in excess of € 20,000 Million Some 200 companies cited biotechnology as their main activity; they employ over 3,000 people and invoice a figure approaching € 500 Million For both groups of firms, annual growth in invoicing, employee numbers and R&D spending approached 20%.

ThE SiTuaTion of ThE SpaniSh BioTEchnology SEcTorHealth care or red biotechnology, in both its therapy and diagnostic aspects, accounts for 39% of the sector. The companies with transverse technology platforms with applications in more than one area are undergoing strong growth and make up 33% of the overall figure. Agrifoodstuffs or green biotech applications account for 18% of the market and industrial or white biotechnology rose to account for 10%, to thus double its weight of the previous year.

Region of Madrid continues to lead in terms of numbers of enterprises, but it is losing ground against the biotech hubs of Catalonia and Andalusia, which are now home to 36% of these companies (18% each). The Valencia Region, the Basque Country and Galicia slightly impro-ved their ratios and round up the list of Autonomous Communities showing the highest concen-trations of biotech industry.

nEw EnTErpriSESThe Autonomous Community of Catalonia, followed by Andalusia and Madrid (respectively showing 30%, 23% and 21% of the new initiatives), have been the most active regions over recent months in terms of biotech company creation.

Table 1. SpaniSh bioTech companieS founded in 2006. Source: aSebio

3p biopharmaceutils Navarre Production of proteins

agroaqua Andalusia Biological purification of water

amplilab Madrid Human healthcare diagnostics

archivel farma Catalonia Tuberculosis vaccine

aromics Catalonia Medicinal drug development platform

artemis bioingeniería Madrid Stem cell bioreactors and in vitro testing systems for medicinal drugs

bacamp Valencia Biological pest control

beyond food Catalonia Functional nutrition

bioalgal marine Andalusia Products derived from seaweeds

bioglutamic Catalonia Biopolymers

biomaslinic Andalusia Biological activity of maslinic acid

biomol informatics Madrid Bio-information systems consultancy

bionanomics Catalonia Bioprocess scaling

bioprodin Murcia Production of proteins

biovevan Andalusia Tissue regeneration

centro mediterráneo de fotobiología Andalusia Development of photoprotective molecules

chemotargets Catalonia Identification of new molecular entities

coretherapix Catalonia Development of cardiac regeneration products

��

�

dropsens Asturias Biosensors

fluidos Supercríticos bioquímicos Andalusia R&D of subproducts from tomatoes

Geadic biotec Catalonia Molecular diagnosis of endometrial cancer

Gendiag Catalonia Genetic diagnosis DNA-Chips

Genetadi Euskadi Phytodiagnosis

Genfis Andalusia Therapeutic studies

hexascreen culture Techonolgies Catalonia Development and manufacture of minibioreactors

histocell Euskadi Tissue engineering

icinetic Andalusia Bio-information systems

ikerchem Euskadi Fine chemistry

inbea Madrid Agrifoodstuff biosensors

inbionova Murcia Biology systems

ingenia biosystems Catalonia Biological water treatment

insecta Andalusia Selective breeding of functional insects

intera Andalusia Therapeutic inhibitors

iVGen Valencia Diagnosis of genetic diseases

laboratorios Vitros Madrid Veterinary allergies

life Sequencing Valencia Ultrafast sequencing

lorgen Gp Andalusia DNA analysis

mellitus Catalonia Medicinal drugs for metabolic syndrome

microbial Catalonia Microbiological analyses

musselect Galicia Aquaculture

nanofar Aragon Nanobiotechnology

neuron biofarma Andalusia Alzheimer therapies

neurosciences technologies Catalonia Screening of neuropathic pain drugs

neuroTech farma Catalonia CNS diagnosis and treatment

omnia molecular Catalonia Development of anti-infectious agents

orphanmed Madrid Research of new indications for rare disease drugs

palau farma Catalonia Medicinal drug development

proJech Science to Technology S.l. Madrid Biomedicine, study of micrometastasis

protein alternatives Madrid Production of recombinant proteins

proteus biosytems Madrid Research and production of new cancer biomarkers

protia Andalusia Structural and functional characteri-sation of proteins

rara avis biotec Valencia Biological pest control

recursos biotecnológicos de atlántico Canary Isles Agrifoodstuffs

Sabiobbi Madrid Commercialisation of aging DNA-Chip

Sanifit Catalonia R&D phytates

Suanfarma biotech SGecr Madrid Biotech project managing body

Sylentis Madrid Therapies based on RNAi

Tcd farma Madrid Development of cancer diagnosis and treatment methods

Tetra Therapeutics Canary Isles Medicinal drug development

Valentia biopharma Valencia Drug development using Drosophila as model

Verbiotech Andalusia Nutraceutics

�

6

BuSinESS DEvElopmEnT acTiviTyIn the latter months, alliances (Table 3) grew both in number and importance. 37% of these alliances have been with an international partner, largely from Europe (17%) or from the U.S. (17%). This improved the sector’s internationalisation profile (in 200� only 32% of the alliances were international) and these were heavily biased towards agreements with the U.S.

Table 3. The main allianceS in The SpaniSh bioTechnoloGy SecTor 2006 february 2007

companies objective

abengoa bioenergy (Sp) / dyadic (uSa) To develop enzyme systems for producing biofuel

abengoa / 25 companies / 27 public bodies Research and development of Bio-ethanol for the automotive sector

advancell / histocell Collaboration in tissue engineering

advancell / protherics (ru) Clinical development of Acadesine

algenex / inia Development of recombinant vaccines in insects

almirall / esteve / uriach / cristax / Galchimia / enantia

Platforms supporting the discovery of innovative medicinal drugs

bionaturis / biomedal R&D and technology transfer

bionaturis / cpd Sample-taking and structural splitting and identi-fication of marine organisms

bionaturis / icinetic Software development for RD&I management

bionaturis / ingeniatrics R&D and technology transfer

bionaturis / neuronbiopharma R&D and technology transfer

bionaturis / noraybio Collaboration and development of software platforms

bionostra (Sp) / mount Sinai hospital (uSa) Development of a vaccine with the H�N1 virus

biopolis / bioproduction consortium (eu) Creation and production of micro-organisms capable of transporting active ingredients

biopolis / Secugen Joint Venture “Life Sequencing”

biopolis / university mohamed V (mor) Study of �00 bacteria strains from the Sahara

biotherapix / digna biotech Idiomatic Pulmonary Fibrosis programme

biotools / capitalbio (china) Development of a biochip programme

biotools / capitalbio (china) / piolab (india) Development and commercialisation of diagnos-tic solutions for the Indian market

bTi / neiker Research into the field of regenerative medicine

cima / brainStorm cell Therapeutics (uSa) Cell therapies against Parkinson’s Disease

digna biotech / chlorogen (uSa) Production of recombinant alfa � interferon from plants

digna biotech / chlorogen (uSa) Commercialisation of porphyria gene therapy

digna biotech / ferrer Commercialisation of a diagnostic test to deter-mine the risk of thrombosis

dracena bioresearch / Tetra Therapeutics Research

esteve(Sp) / yiwu huayi (chi) Fine chemistry

Executivesummary

1

7

Grifols / hospital German Trias / autonomous university of barcelona

Gene therapy for treatment of self-immunity diseases

icinetic / newbiotechnic Development of a DNA analysis tool

indas biotech / uma / andalusia regional Government Bone regeneration therapy

integromics / bio-it-alliance Personalised medicine

inGenaSa / prionics Commercialisation of products in Spain

integromics / biosolution (fra) Commercialisation of products in France

integromics / discovery Scientific (can) Commercialisation of products in Canada

integromics / human workflows (uSa) Business development/ consultancy

iSdin / advancell Innovative nanomedicines for treating skin diseases

iSdin / digna biotech Development of the p1�� peptide in scleroderma

iucT / Thrombotargets Research

iuTc / urquima Research

merck farma y Química / Vertisol Pearlescent pigment applications as thermal and solar protectors

natraceutical (Sp) / panadero Gropus (iTa) Joint Venture (Cake friends) for the commerciali-sation of functional products

neocodex / la Jolla university (uSa) Trailing genetic alterations in biological samples from cancer patients

neuropharma / JSW research (uSa) Development and commercialisation of transge-nic mouse model of neurodegenerative diseases

neuropharma / progenika / proteomika / oWl / newbiotechnic / faes farma / rovi

Fine-tuning research processes in the pre-clini-cal phase

noraybio (Sp) / aethia (iTa) Bio-information system solutions for genomic studies

noraybio (Sp) / biodynamics (ru) Predictive pharmacokinetic models

oryzon Genomics / ferrer / Siemens / leti / nge-nasa / advancell / Solutex

Development of drugs for various kinds of highly prevalent cancer

oryzon Genomics / reig Jofré Molecular diagnosis of endometrial cancer

SeaWeed canarias / newbiotechnic Co-development and commercialisation of inno-vative agricultural products

Sistemas Genómicos / clínica Quirón Commercialisation a domestic DNA storage service

Suanfarma (Sp) / biocon (ind) Co-development of new proteins and small the-rapeutic molecules

Suanfarma (Sp) / billam aG+a12 (ru)Platform for facilitating the quotation of Spanish biotech companies on the London AIM Stock Market

Thrombotargets / uah Production of the TT-110 protein

Thrombotargets (Sp) / asinex (ruS) Discovery of medicinal drugs

Thrombotargets (Sp) / Seps (hol) Discovery of medicinal drugs

Thrombotargets / Villapharma Discovery of medicinal drugs

Zeltia / rovi / faes farma / lipotec / dendrico Drug Delivery Systems

8

STraTEgic prioriTiESIn the analysis of strategic priorities (Table 2) carried out among ASEBIO members, the greatest importance was awarded to operations relating to product launches onto the market, above that of internationalisation or knowledge acquisition.

Table 2. analySiS of The STraTeGic prioriTieS of SpaniSh bioTech compa-nieS for 2007. Source: aSebio

importance 2007

importance 2006

Variation

product launches onto the market 93 8� 9

acquire knowledge and/or technology 91 78 13

expand operations 89 8� �

internationalise 88 86 2

contract or form alliances with public centres 8� 72 12

enter into clinical/ field trials/ scaling phases 80 6� 16

refocus product development 77 �6 21

refocus r&d activities 73 �2 21

form alliances with other biotech companies 71 78 -7

form alliances with other user companies (pharma, foods) 67 78 -11

form a joint venture 67 66 1

recruit foreign experts 66 �2 1�

licence – in technology 6� �0 1�

licence – out technology 63 66 -�

externalise production 62 �� 8

reduce operations �3 28 1�

Take over a company 38 �8 -11

merge with another company 36 �0 -�

Executivesummary

1

9

inDuSTrial propErTy anD KnowlEDgE gEnEraTionThe analysis made for ASEBIO by the Community of Madrid Circle for Biotech Innovation, found there were a total of 126 biotechnology patents applied for and awarded to Spanish companies in 2006.

These patents are held by �8 companies, in the number of awards the most outstanding of which is the Cima Biomedicine Project, with nineteen awards, Cellerix with eight, and Advan-cell and Grifols with six each (Graph 1).

Graph 1. companieS ShoWinG moST acTiViTy in obTaininG and applyinG for bioTechnoloGy paTenTS in 2006.

In the last year, companies members of ASEBIO appear as authors in 36 international scientific publications. The most notable in terms of the number of articles are Neocodex and Pharma Mar. (Table �).

Table 4. inTernaTional publicaTionS SiGned by SpaniSh companieS in 2006. Source: aSebio

company article Title publication

neocodex Molecular analysis of estrogen receptor alpha gene AGATA haplotype and SNP12 in Euro-pean populations: potential protective effect for cryptorchidism and lack of association with male infertility.

Human Reproduction

advancell Atherogenic and inflammatory profile of human arterial endothelial cells (HUAEC) in response to LDL subfractions

Clinica Quimica Acta

advancell Polypodium leucotomos extract: antioxidant activity and disposition.

Toxicology In Vitro

pharmamar Kahalalide F and ES28�: potent anticancer agents from marine molluscs

Progress in Molecular and Subcellular Biology

10

pharmamar Trabectedin: Ecteinascidin 7�3, Ecteinascidin-7�3, ET 7�3, ET-7�3, NSC 68�766.

Drugs in R & D

pharmamar Development of a liquid chromatography/tan-dem mass spectrometry assay for the quan-tification of PM0273�, a novel antineoplastic agent, in dog plasma.

Rapid Communications in Mass Spectrometry

pharmamar Acerolide, a new cytotoxic cembranolide from the soft coral Pseudopterogorgia acerosa.

Natural Products Research

pharmamar Granulatamides A and B, cytotoxic tryptami-ne derivatives from the soft coral Eunicella granulata.

Natural Products Research

pharmamar Alterations in intestinal contractility during inflammation are caused by both smooth mus-cle damage and specific receptor-mediated mechanisms

Croatian Medical Journal

pharmamar Quantitative analysis of Variolin analog (PM01218) in mouse and rat plasma by high-performance liquid chromatography/electros-pray ionization tandem mass spectrometry.

Journal of Chromatography B

pharmamar Adding pharmacogenomics to the develo-pment of new marine-derived anticancer agents.

Journal of Translational medicine

neuropharma Targeting Beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

Current Pharmaceuti-cal Design

neocodex The therapeutic potential of the calpain family: new aspects.

Drug Discovery Today.

neocodex Association of genetic markers within the KIT and KITLG genes with human male infertility.

Human Reproduction

neocodex Lack of Association Between NOS3 Glu298Asp and Breast Cancer Risk: a Case-control Study.

Breast Cancer Research and Treatment

neocodex Bone morphogenetic protein 1� (BMP1�) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).

Pharmacogenet Genomics.

neocodex Pyrosequencing protocol requiring a unique biotinylated primer.

Clinical Chemistry and Laboratory Medicine

neocodex Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis.

Bone

mSd españa Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Nature

lilly S.a. (madrid)

[Fragility non-spinal fractures in a cohort of �,201 women aged 6� years and older during a 3-year follow-up]

Clinical Medicine

Executivesummary

1

11

lilly S.a. (madrid)

A novel class of AMPA receptor allosteric mo-dulators. Part 1: design, synthesis, and SAR of 3-aryl-�-cyano-�-substituted-heteroaryl-2-car-boxylic acid derivatives.

Bioorganic and Medici-nal Chemistry Letters

lilly S.a. (madrid)

Improvement in social functioning in out-patients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.

Progress in Neuropsy-chopharmacology and Biological Psychiatry

lilly S.a. (madrid)

Optimization of diffusion-filtered NMR expe-riments for selective suppression of residual non-deuterated solvent and water signals from 1H NMR spectra of organic compounds.

Journal of Organic Chemistry

lilly S.a. (madrid)

[Idiopathic short stature: definition and treatment]

Pediatric Annals

mSd españa Studies on Morinia: recognition of Morinia lon-giappendiculata sp. nov. as a new endophytic fungus, and a new circumscription of Morinia pestalozzioides.

Mycologia

mSd españa Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.

Cardiovascular Diabetology

bTi biotechnology institute

New insights into and novel applications for platelet-rich fibrin therapies

Trends y Biotechnology

ceifer Influence of analytical and biological varia-tion on the clinical interpretation of seminal parameters.

Human Reproduction

instituto biomar Phenolic marine natural products as aldose reductase inhibitors.

Journal of Natural Products

bioalma Status of text-mining techniques applied to biomedical text.

Drug Discovery Today

Sensia Multi-analyte SPR immunoassays for environ-mental biosensing of pesticides.

Annals of Bioanalitical Chemistry

Sensia Optical immunosensor for fast and sensitive detection of DDT and related compounds in river water samples.

Biosens Bioelectron.

Sensia Determination of carbaryl in natural water samples by a surface plasmon resonance flow-through immunosensor.

Biosens Bioelectron.

Vircell Value of serological testing for diagnosis of legionellosis in outbreak patients.

Journal of Clinical Microbiology

nbT Generation, annotation and analysis of ESTs from Trichoderma harzianum

BMC Genomics

Genetrix Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells.

Journal of Cell Science

12

human hEalTh carE (rED BioTEchnology)The portfolio of products (both in preclinical and clinical phases) has diversified considerably over recent months. Among the areas showing greatest potential, the most outstanding are oncology, infectious diseases, diabetes, self-immunity disorders, and pathologies relating to the central nervous system, with special emphasis on neurodegenerative diseases.

In the diagnosis market, the most important news for the sector in 2006 was the definition of a new legal framework for genetic analyses. In the meantime, the diagnosis area continued to show growth in the number new of companies created, and in parallel, the more veteran com-panies made ground in their consolidation.

A further two areas within healthcare biotechnology (support technologies for the discovery of drugs and projects focussed on the manufacturing of biological products), were especially dynamic in 2006.

agriculTurE, livESTocK anD fooD (grEEn Bio-TEchnology)The use of different modern biotech applications in the food industry is becoming increasingly more important and the signs are that it will be ubiquitous within very few years. The potential of diagnosis and traceability techniques or the opportunities they offer for increasing added value and safety in food products are the main vectors boosting the growth of an area in which there are now over �0 Spanish biotech companies.

As far as the cultivation of genetically improved (transge-nic) plant varieties are concerned, in 2006 Spain continued to be the European benchmark with a total of �3,667 hec-tares under cultivation. After 9 years of cultivation without a single adverse effect on people or on the environment, Catalonia and Aragon, the Autonomous Communities most prone to Ostrinia nubilalis attacks from the European corn borer, continued to be the largest sowers of transgenic mai-ze protected against this pest.

EnErgy anD BioprocESSES (whiTE BioTEchnology)In the industrial biotech sector, the most outstanding applications belong to the bioenergy areas where Spain plays a key international role through biofuel manufacturing companies and where national biotech companies are becoming better positioned.

Executivesummary

1

ThE financial EnvironmEnTThere has been evidence of increasing public and private capital availability for initial rounds of investment, however, the generalised weakness of European biotechnology to access “expan-sion capital” is becoming ever more acute in the case of Spain.

The largest scale operations in 2006 (Table �) were undertaken by Neuropharma, Palau Phar-ma, Natracéutical, Abengoa and Cellerix.

Table 5. main financial operaTionS in The SpaniSh bioTechnoloGy SecTor in 2006 february 2007

company investors operationinvest. amount

(mill / euro)

era biotech Invertec, Reus Capital Riesgo, Talde Capial II and Uninvest and others

Capital increase 1.�

palau farma Capital increase �0.0

oryzon Ferrer Capital increase Not available

coreTherapix Not available Initial capital Not available

biocontrol Technologies Uninvest Initial capital 2�%

archivel Innocat Capital increase 1 (11.33%)

mellitus BBR (�0%) Capital increase 0.��

forte farma Natraceutical (100%) Take-over 82.0

natracéutical BBR (�.�8%) Increase in shareholding

Not available

dyadyc Abengoa Partial takeover 7.8

Sylentis Zeltia Initial capital 0.�

cellerix Kutxa Donation 0.9�

cellerix ENISA Participating loan 0.��

bioalgal marine Jarquil Group Take-over Not available

Keramat Inibsa Capital increase 0.2

crystax Najeti Capital, Barcelona Emprèn and Invertec

Capital increase 3.0

ibersen Asac farma, Iberma and others Initial capital Not available

albiex Esteve and others Initial capital Not available

inibsa Natracéutical Partial takeover 1,9

cellerix Various Capital increase 3,3

neuropharma Zeltia and other private shareholders

Capital increase 31.0

Sistemas Genómicos Spanish Ministry of Education and Science

Returnable loan 3,�

King food australia Natraceutical (100%) Take-over �,�

digna biotech Not available Capital increase 1,3

Seaweed Not available Capital increase 1,2

noraybio Group ORZA Capital increase 1,8

histocell Noraybio Group (�1º%) Take-over Not available

biomar institute Fernández Puentes Family, Allveri-tas Inversiones, ADE Capital

Capital increase 1.3+issue premium 2.6

13

company guide

2

ASEBIOCompany Guide

2.

16

a&B laboratorios en Biotecnología, S.a.Sector: chemical- biological

missionDevelopment of bioproducts for biodetergents and bioremediation products.

productsResearch, manufacturing and marketing of industrial chemical and biological products.

interest areas for future collaborationsSelection of natural micro-organisms.Enzyme production.Industrial fermentation.Ecodesign.

contactPaduleta, esquina JundizVitoria0101� Alava - Spain

Tel: (+3�) 9� �29 16 16Fax: (+3�) 9� �29 29 39http://www.ab-laboratorios.com

Jon Kepa izaguirreGeneral Managerkepa@ab-laboratorios.com

advancell in vitro cell Technologies, S.l.Sector: human health care / Therapeutic

missionTo contribute to obtaining new medicines through new technologies acquired in Spanish universities and / or developed by Advancell.

Developing and marketing “in vitro” cell models in service or product form (kits).Developing Advancell technologies and products until the clinical concept trial stage.

productsCacoReady: a tool designed to optimise pre-clinical screening regarding the viability of orally administering compounds of a different nature.HUVECs: Umbilical vein endothelial cells.HUAECs: Umbilical artery endothelial cells.Microsomes.Adipocytes.Others.KITS (under development): AdipoCell /MicrosomeCell.

ServicesScreening.Customised research: ADME, cancer, inflammation, biocompatibility, cosmetics and skin biology.Pharmaceutical developments.ADV-P1 (chronic lymphocytic leukaemia B cells).ADV-P2 (diabetes).ADV-P3 (psoriasis).ADV-P� ( haemodynamics).ADV-P� ( solid tumour progression).

interest areas for future collaborationsTechnologies or products in early phases, complementary or with strategic value for ADVANCELL:

Cancer.Cosmetics.Others.

contactParc Científic de Barcelona, BaldiriReixac, 10-1208028 Barcelona - Spain

Tel: (+3�) 93 �03 �� ��Fax: (+3�) 93 �03 �� ��http://www.advancell.net

luis ruiz ÁvilaGeneral Manageradvancell@advancell.net

company guide2.

17

company guide

2

alimentary Extractive Solutions, S.l. (SoluTEX)Sector: fine chemicals

missionBe the world-leading company in the production of ingredients by supercritical CO2 technologies for the pharmaceutical, cosmetic, nutritional, food and beverage industries.

productsEPA (Eicosapentaenoic Acid) until 9�%, DHA (Docosahexaenoic Acid) until 8�%, SDA (Stearidonic Acid) until �0%, Omega-3 PUFAS until 9�%, Lycopene until �0%, Terpeneless Citrus Oils in the desired folding, Sesquiterpeneless Citrus Oils in the desired folding, Terpenes, Sesquiterpenes, Magnetic Nanoparticles

interest areas for future collaborationsWe look for partners interested in collaborating in clinical studies with products containing our ingredients. We also are interested in partnering with companies with complementary technologies with ours, in order to increase competitiveness or technological development.

contactParque Científico de MadridZona Industrial OesteTres Cantos28760 Madrid - Spain

Tel: (3�) 91 806 0� 77Fax: (3�) 91 806 06 0�http://www.solutex.us

fernando G. SantosCommercial & Marketing Directorfgsantos@solutex.es

amgen, S.a.Sector: biotechnology, medicines for human use

missionTo be the best company in human therapies, using science and patient service innovation.

productsTreatments for the complementary care cancer and anaemia, rheumatoid arthritis and other autoimmune diseases. Amgen carries out active research programmes in nephrology, haematology, oncology, inflammations, metabolic, and bone disorders and neuroscience.

contactWorld Trade Center BarcelonaMuelle Barcelona Edificio Sur, 8ª planta08039 Barcelona - Spain

Tel: (3�) 93 600 19 00Fax: (3�) 93 301 90 09http://www.amgen.es

Juan carlos estebanCorporate Communicationjesteban@amgen.com

archivel pharma, S.lSector: pharma

missionClinical development of vaccines

productsTherapeutic vaccine against Latent Tuberculosis Infection

missionResearch and Development on new biological drugs

contactCtra. de Mata, 97 Esc.2, pl. 1Pol. Mata-RocafondaMataró0830� Barcelona - Spain

Tel: (+3�) 93 790 7� 22Fax: (+3�) 93 790 86 32http://www.archivelfarma.com

Jaume amatGeneral Directorarchivel@archivelfarma.com

18

asac pharma, S.a.Sector: human health care

missionResearch into drugs based on the active principles of medicinal plants, including those from traditional cultures and uses.

productsA wide range of products comprising the following lines:

Cosmetics.Dietetics.Phytobioextracts.Pharmaceutical specialities.Raw materials.

ServicesManufacturing of Pharmaceutical Specialities.

contactSagitario 1�AlicanteAlicante - Spain

Tel: (+3�) 96 �28 03 12Fax: (+3�) 96 �11 73 06http://www.asac.net

angel Sánchez-covisa VillaChairmanscovisa@asac.net

Bayer Bioscience n.v.Sector: agriculture, environment-biotechnology

missionBayer Bioscience N.V. is one of the main biotech innovation centres of Bayer CropScience AG, a subgroup of Bayer AG. The objective of the excellence centre is to integrate plant biotech research with the business demands of BayerBioscience to optimise innovating processes in a responsible and sustainable way.Drawing up crop management solutions (pest and weed control), researchers use genetic engineering to discover new features.

productsPatents, know how.Crops of high agronomic interest, with new features applied to modern crossing techniques.Interest Areas for Future Collaborations.Agriculture, Environment-Biotechnology.

contactTechnologiepark 38B-90�2 GentBelgium

Tel: (+32) 92 �3 0� 68Fax: (+32) 2� 3� 63 31http://www.bayercropscience.com

Stefania meloniRegistration Manager Spain and UK-Regulatory Affairs

stefania.meloni@bayercropscience.com

19

company guide

2

BiobideSector: high Throughput Screening (hTS)

missionBiobide is a newly founded biotech company for the testing or automatic screening of new potential drugs using the zebra fish as the model animal. Biobide is structured on a technological platform that integrates zebra fish disease models, robotics, optical analysis and bio-IT tools, producing highly informative, low-cost results that give rise to a competitive advantage for companies involved in pharmaceutical product development.

productsDevelopment of animal models of human diseases.Target identification and validation.In vivo screening ( High Throughput molecule screening).General, specific and genetic toxicity studies.Teratogenesis studies.ADME studies.

ServicesFunctional genomics services.Action mechanism studies.Protein function studies.Biological route dissection.

interest areas for future collaborationsThe collaboration agreements subscribed by the company include both public and private research centres and companies. Company policy consists of setting up agreements with agents who not only possess quality research capacity but also undertake applied research projects that are complementary to our company’s own activities, thus maximising the investment on all fronts.

contactPaseo Mikeletegi, �6Donostia - San Sebastián20009 Guipúzcoa - Spain

Tel: (+3�) 9� 330 93 60Fax: (+3�) 9� 330 93 70http://www.biobide.es

idoia ruiz de azuaGeneral Managerruizdeazua@biobide.es

Bio-ges StartersSector: biotechnology

productsStarters for the agricultural and food industry.

contactPº Condesa de Sagasta, 10León2�001 León - Spain

Tel: (+3�) 98 787 61 3�Fax: (+3�) 98 722 �6 38

agustín florez moranManaging Directormarian@serfisa.es

20

Biokit S.a.Sector: health care

missionResearch, production and distribution of clinical diagnostic reagents (IVD).

productsOver 120 diagnostic products for the field of infectious diseases and plasmatic proteins.Reagents: � differentiated products depending on the different technologies used:

Manual tests.Immunoturbimetric tests.Immunochromatographic tests.Immunoenzyme assay.Chemoluminescence.

Raw materials: High quality antigens for hepatitis B, rubella, toxoplasma, Lyme disease, syphilis, VHS1 and streptolysin-O, together with antibodies for hepatitis B, streptolysin-O, rotavirus, PCR and ferritin.

contactCan Malé, Lliçà d´AmuntBarcelona08186 Barcelona - Spain

Tel: (+3�) 93 860 90 00Fax: (+3�) 93 860 90 29http://www.biokit.com

Joan GuixerQuality Assurance Managerjguixer@biokit.com

Biomedal S.l.Sector: biotechnology

missionTo develop new, innovating technologies for the progress of post- genomic research and the efficient industrial production of new biomolecules that are useful for society.

productsGenetic engineering tools for cloning, expression and purification of recombinant proteins and their related products.

ServicesThe design of specialised strains, production of recombinant proteins, sequencing, DNA synthesis, DNA analysis, consultancy and technology transfer.

interest areas for future collaborationsExpression and purification of recombinant proteins, protein analysis, molecular diagnostics, proteomics, etc.

contactAvda. Américo Vespucio, �. � Planta 1, módulo 12 �1092 Sevilla - Spain

Tel: (+3�) 9� �08 12 76Fax: (+3�) 9� �08 12 79http://www.biomedal.com

Ángel cebolla ramírezGeneral Manageracebolla@biomedal.com

company guide

2

Bionostra, S.l.Sector: foodstuffs/ animal healthcare diagnostics/ diagnostics/ production

missionTo develop new molecular biology applications (genomics, proteomics, HTS, combining biology, recombinants, etc.) in order to identify molecules with industrial/ pharmaceutical applications and to complete the range of diagnostic and detection kits available.

productsProduction of antibodies and recombinant proteins.Kit formulation.Vaccines.Microarrays.

ServicesDetection and quantification of GMOs in foods.Identification and authentication of species.Genotyping.Marker selection.

contactRonda Poniente �, 2º C y DTres Cantos28760 Madrid - Spain

Tel: (+3�) 91 806 00 68Fax: (+3�) 91 806 03 �9http://www.bionostra.com

Juan carlos del castilloManaging Directorbionostra@bionostra.com

Biopolis, S.l.Sector: industrial biotechnology

mission Research projects and microbial biotech development.

productsThe design, selection, characterisation and production by fermentation of bacteria, yeasts and filamentous fungi and cellular metabolites obtained from these (proteins, enzymes, nucleic acids, polysaccharides). Fine tuning of its industrial applications in the agrifoodstuff and pharmachemical fields.

contactPolígono la Coma s/nPaterna�6980 Valencia - Spain

Tel: (+3�) 96 316 02 99Fax: (+3�) 96 316 03 67http://www.biopolis.es

marta TortajadaHead of the Molecular Biology Laboratory

marta.tortajada@biopolis.es

21

22

Bioreply, S.l.Sector: human health care, animal health care, agriculture and food

missionThe use of ultra-weak photon emissions of biological systems as an analytical tool.The building of bio-sensors and chemical sensors.

productsELISAs for plague pesticides; Tiabendazol, Imazalil and chlorpyrifos.Molecular probe for mercury detection.

ServicesMeasurement of photon emissions: Toxicity assays.Detection of heavy metals: mercury.

interest areas for future collaborationsNanotechnology.

contactAsensi, 2� �ª PlantaCastellón12002 Castellón - Spain

Tel: (+3�) 696 919 787Fax: (+3�) 96� 202 36�http://www.bioreply.com

Javier ramírezLegally Appointed Representativejramirez@bioreply.com

Bioorganic research and Services S.l. (Bionaturis)Sector: bionaTuriS offers products as well as research-technological services to all user sectors of red, Green and White biotechnology. These include pharmaceutical, food-agriculture, cosmetic, natural medicine, or nutraceutical, among others.

missionUsing knowledge to help society.Bionaturis´ R&D+i area is looking for partner interested in: creating international network, co-development of research projects, technology transfer agreements, licensing-in, licensing-out. Bionaturis has established external R&D relationships with other partners in the industry and academic institutions into the following areas: Red Biotechnology (human health); pre-clinical investigations; pre-clinical studies; nanomedicine; drug delivery.

productsBNT PRODUCTS: wide range of added value products to its customers. Extracts, fractions, libraries, quality chemicals, monoclonal antibodies, diagnosis Kits, set a broad catalogue where enterprises and research centres can meet their needs.

ServicesBNT PLATFORMS: BIONATURIS offers enterprises and research centres the most up-to-date technologies within our range of activity SIDENA HTD (High Throughput Dereplication), Protein Interaction Analysis (Bioacore), Array Systems, DNA sequencing.

contactDoctor Duarte de Acosta nº �. Polígono Industrial Las Salinas.El Puerto de Santa María11�00 Cádiz - Spain

Tel: (+3�) 9� 6�� 73 �6Fax: (+3�) 9� 6�� 73 �6http://www.bionaturis.com

Victor infanteR&D Directorvictor.infante@bionaturis.com

23

company guide

2

BiotSectorpower. agroambiental. nourishing.

missionEnterprise group of the biotechnological sector whose Know-How is fundamentally microbiological. The objectives are diversified through the different companies that compose the Biot group. The development and use of different microbial bioprocesos for the production from renewable energies are included among them, particularly the biocombustibles; as well as the application of the microorganism for agriculture, the aquaculture and the environment. Solutions are contributed technological microbial for the nourishing industry, the security and the process control and products.

productsenergygen l.l.c. : Microbial bioprocesses for obtaining renewable energies. Biofuels. Advantage of remainders.biotmicrogen l.l.c. : Fermentative bioprocesses for the nourishing industry. Probiotic foods. Functional foods of microbial origin.microgenambiental l.l.c. : Microbiology for agriculture and aquaculture. Security and microbiological control. Water purification. Processes of biorremediation.biotgensystem.l.l.c. : Management of projects of I+D+i. Management and Protection of the Knowledge. Scientist-technical human resources. Specialized formation. Integrated systems of Security, Quality and Environment, for the biotechnological sector.

interest areas for future collaborationsRenewable energies. Remainders. Biofuels.Functional food production of microbial origin. Nutrition-health.Nourishing industry. Security and microbiological control. Residual, industrial and urban water purification. Biorremediation.Projects of I+D+i in cooperation.Human resources for the Biotechnology.

contactAv. Innovación 1. Edificio BIC.Parque Tecnológico Ciencias de la Salud.18100 ArmillaGranada - Spain

Tel: (+3�) 9� 87� 06 18Fax: (+3�) 9� 830 1� 77http://www.biot.es

agustín lasserrotGeneral Directordireccion@biot.es

Biotecnet i+D, S.a.Sector: human health care

contactAlpedrete, 20Madrid280�� Madrid - Spain

Tel: (+3�) 91 �68 08 00Fax: (+3�) 91 �68 �9 3�

José anduizaManaging Directorpquintan@faes.es

2�

Biotherapix molecular medicines S.l.u.Sectorbiotechnology

missionBiotherapix Molecular Medicines S.L.U. is a company belonging to the Genetrix Group, which specialises in human antibodies and molecules derived from them.Its activity centres of the generation of new therapeutic molecules based on antibodies for the treatment of infectious, degenerative and inflammatory diseases. Its technology platforms make it a company competitive in the development of therapeutic molecules of a biological origin.

interest areas for future collaborationsMolecular therapy.Protein biology.Protein production and purification systems.Development of therapeutic antibodies.Inflammation.Infectious diseases.

contactMarconi, 1Tres Cantos28760 Madrid - Spain

Tel: (+3�) 91 80� 92 6�Fax: (+3�) 91 80� 92 63http://www.biotherapix.com

lourdes lapeñaFinancial Affairs Managerllapena@genetrix.es

Biotools B&m labs, S.a.Sector: diagnostics and r&d.

missionDevelopment and commercialisation of innovating technologies and products aimed to provide the diagnostic, biomedical research and Agfood sectors with high quality and easy to use kits and reagents, positioning Biotools as a leading player in the diagnostic market based upon Real Time DNA amplification techniques

ServicesDevelopment and distribution of Real Time diagnostic kits and research reagents and assays.

productsReal Time Diagnostic Kits for Tuberculosis, Listeria, Legionella and other infectious diseases, molecular biology reagents (polymerases, Real Time Kits, agarose, markers, etc.), as well as Real Time KIts for detection of GMOs and identification of animal species. All our kits are based upon Biotools own and patented LIONPROBES and GELIFICATION Technology platforms.

contactValle de Tobalina �2, nave �3Madrid28021 Madrid - Spain

Tel: (+3�) 91 710 00 7�Fax: (+3�) 91 �0� 31 18http://www.biotools.net

michael SohnBusiness Development and Marketing Directormichaelsohn@biotools.net

company guide

2

Bosques naturales, S.a.Sector: environment

missionProduction of quality hardwoods and topical woods of high economic value, destined for the world transformation industry.

productsAgroforest plantations previously undertaken by sale of the forest canopy (trees).Entire plantations (by estate or part estate).Company whose asset is a product, the estate, infrastructures, trees planted and the financial resources necessary to develop this activity throughout the production cycle.Gift Tree

ServicesSale to internal secondary market.

contactGran Vía, 39Madrid28013 Madrid - Spain

Tel: (+3�) 91 360 �2 00Fax: (+3�) 91 360 �2 01http://www.bosquesnaturales.com

José luis García de angelaCorporate Development Managerdangela@bosquesnaturales.com

Bristol-myers Squibb, S.l.Sector: health care

missionTo improve and prolong human life by marketing drugs of the highest quality and healthcare products.

productsDrugs and other products in the following therapeutic areas:

Cancer.Cardiovascular/ metabolism.Nervous System.Pain.Infectious diseases.Antibiotics.Diagnostic imagery.Infant nutrition.Ostomy pouches.Artificial skin.

contactAlmansa, 101Madrid280�0 Madrid - Spain

Tel: (+3�) 91 ��6 �� �7Fax: (+3�) 91 ��6 �� 01http://www.bms.com

concepción SerranoManager for Institutional Records and Relations

concha.serrano@bms.com

2�

26

BTi Biotechnology instituteSector: biotechnology and human health care

missionContinued research and development of new bone regeneration products and techniques.

productsPlasma rich in growth factors (PRGF).Research and development.Dental implants.Surgical and prosthetic instruments.Publisher of “Dental Dialogue”.BTI Scan ( Diagnostic software for oral implants and oral surgery).Continuing in-service training centre.

interest areas for future collaborationsTissue engineering and bone regeneration.

contactSan Antonio, 1� -�ª PlantaVitoria 0100� Alava - Spain

Tel: (+3�) 9� �1� 00 2�Fax: (+3�) 9� �13 �2 03http://www.bti-implant.es http://www.prgf.net

dr. eduardo anitua aldecoaScientific Affairs Manager eduardo.anitua@bti-implant.es

calantia Biotech, S.lSector: bioenergy

missionContribute to increase efficiency of the energy sector by means of biotechnological approaches.

productsAvant garde research that contributes to eliminate technological barriers in the bioenergetic sector through identification and improvement of bioenergetic crops, use of biotechnological procedures aimed at obtaining high performance in the biofuels production and the selection of candidate genes and the development of genetic transformation procedures to increase biomass production Additionally, Calantia uses biotech approaches to increase efficiency in the production of bioproducts with potential industrial use, developing the integral concept of biorefinery.

contactPz. Legión Española, 13 �6BValencia�6010 Valencia -Spain

Tel: +3� 96 362 87 38Fax: +3� 96 339 20 32http://www.calantia.com

mamen lladróGeneral Directormlladro@calantia.com

canvax Biotech S.l.Sector: human health care

missionThe search for antigens for vaccines.

productsOwn technology for the identification of antigens inducing T CD�+ and CD8+ response.

interest areas for future collaborationsVaccine sector, model animals for protection against infections.

contactAlcalde Velasco Navarro 10, �-IzqCórdoba1�00� Córdoba - Spain

Tel: (+3�) 9� 7�2 08 70Fax: (+3�) 9� 7�2 17 92

elier paz rojasManaging Directore.paz@dominion.es

27

company guide

2

ceifer, S.l.Sector: assisted reproduction centres

missionHuman fertility study and research.

productsAssisted reproduction techniques, freezing of human fertility cells.

contactMartínez Campos, 1. 1º AGranada1800� Granada - Spain

Tel: (+3�) 9� 82� �1 12Fax: (+3�) 9� 82� �1 3�http://www.ceifer.com

Juan pablo ramírez lópezGeneral Managerinfo@ceifer.com

cellerix, S.l.Sector: biotechnology

missionCellerix is a biotech company belonging to the Genetrix Group, which develops and produces innovating medicines based on the use of adult origin stem cells. The company is carrying out clinical trials both for the treatment of fistulas and for skin regeneration.

productsCellerix is developing three products: Cx �01, Cx �01 and Cx 601. Cx �01 is a new alternative to the surgical treatment of fistulas, including those affecting patients with Crohn’s disease. It is currently being assessed in a Phase II multicentre clinical trial. This product, suitable for complex perianal fistulas, obtained the Orphan Medicinal Product designation from the EMEA in July 200�. CX �01 comprises a sheet of chimeric skin, currently at the advanced preclinical stage. This is indicated for the treatment of Epidermolysis bullosa, a congenital defect that gives rise to the formation of blisters on the skin at the slightest touch. This indication complies with orphan medicinal product requirements. CX 601 is an innovative approach for improving the evolution of sutures that usually lead to scarring problems, such as the colon anastomosis. This is currently at the preclinical stage. Both Cx �01 and Cx 601 are based on the use of adult stem cells from the patient’s own adipose tissue. Cx�01 is a chimeric skin composed of keratinocytes from the patient and fibrobalsts from a donor.

interest areas for future collaborationsCell therapy.Regenerative medicine.Tissue engineering.Cell medicines.Regulatory issues concerning cell therapy.

contactMarconi, 1Tres Cantos28760 Madrid - Spain

Tel: (+3�) 91 80� 92 6�Fax: (+3�) 91 80� 92 63http://www.cellerix.es

loudes lapeñaFinancial Affairs Managerllapena@genetrix.es

28

centro nacional de investigaciones oncológicas, cnio (The national oncological research centre)Sector: human health care

missionBasic and applied research under an integrated approach, fostering the interaction of basic research with of molecular diagnostics programmes and of the discovery of new drugs, all supported by a solid equipment and technical services infrastructure.

ServicesUndertaking research to enable the new, more efficient diagnosis and treatment methods to be obtained for oncological diseases.The transfer of scientific knowledge into clinical practice, so that scientific progress has an effect on our healthcare system as early as possible, and thus on patient welfare.The transfer of technology developed in the CNIO to innovating companies.To set up a new and more effective management system in the European scientific environment.

contactMelchor Fernández Almagro, 3 Madrid28029 Madrid - Spain

Tel: (+3�) 91 22� 69 00Fax: (+3�) 91 22� 69 80http://www.cnio.es

ignacio casalBiotechnology Programme Manageroficina@cnio.es

consejo Superior de investigaciones científicas, cSic (The higher council for Scientific research)missionA public research body, under the auspices of the Spanish Ministry of Science and Technology, that provides research capacity and human resources and materials in the development of new scientific knowledge and the transformation of these into processes and products of social and economic interest.

ServicesTo draw up and execute scientific and technological research projects.To draw up and execute collaboration contracts and agreements with companies and with other social agents.To contribute to the analysis and selection of future scientific and technological aims and to advise public administrations on research and technological innovation matters.To foster progress in basic and applied research.To collaborate with the Regional Governments in subscribed research activities.To collaborate with the universities in research and higher education activities.To develop training programmes for researchers and technicians working in the field of science and technology.To collaborate with the National R&D Plan in advisory and management tasks commissioned and with the Regional Governments who request this in the undertaking of their science policies.

interest areas for future collaborationsProjects in all the biotechnology and biomedicine areas and at the interface between biotechnology and organic chemistry, analytical chemistry, food technology, applied physics, etc.Collaboration with universities, technological centres, industries., etc. to enhance the flow that transforms basic science into social well-being.

contactSerrano 117Madrid28006 Madrid - Spain

Tel: (+3�) 91 �8� �3 01Fax: (+3�) 91 �8� �2 87http://www.csic.es

prof. José m.Guisán Seijas Manager of the Technology Transfer Office

ott@csic.es

29

company guide

2

Digna Biotech, S.l.Sector: biotechnology

missionTo give value to the research undertaken in the CIMA (University of Navarre Applied Medical Research Centre) by means of preclinical and clinical development of the intellectual property generated by the researchers there.

productsUnder development

TGF-B1.IFN.

In the pipelineCardiotrophin.Anti-EPCR.SnRNPUmod.Ad/SFV.Early diagnosis of hepatocarcinoma.Anfirregulina in acute hepatic diseases.

contactBoix y Morer 6, 8ºMadrid28003 Madrid - Spain

Tel: (+3�) 91 18� 2� 10Fax: (+3�) 91 18� 2� 19http://www.dignabiotech.com

maite SoriaManagerial Secretarymsoria@dignabiotech.com

Dominion pharmakineSector: human health care

missionBiopharmaceutics focused on the development of products and services that foster advances in the research, diagnosis and treatment of cancer and metastasis.

ServicesPreclinical assessment of compounds with anti-tumour, anti-angiogenic or anti-metastasis activity.Cultures of primary tissue, tissue arrays, cell-arrays, conditioned media, tumour spheroids.Clinical diagnosis support services: detection of circulating tumour cells, molecular cytogenetics, etc.Interest Areas for Future Collaborations.New anti-tumour compounds.Advances in Diagnostic Methods for the different pathologies related to early detection of the possibility of metastasis.Advances in prognosis methods in cancer patients.

contactParque Tecnológico de Vizcaya Edif. 801-A, 1ª plantaDerio�8160 Vizcaya - Spain

tel.: (+3�) 9� �31 70 37fax: (+3�) 9� �31 70 39http://www.pharmakine.com

lorea mendozalmendoza@pharmakine.com

30

Dracena Bioresearch canarias S.l.Sector: biomedicine

missionTo establish competitive alliances with research and industry for new molecule development.To consolidate the undertaking of clinical trials in the Canary Isles.In the medium term, our objective is to manage clinical studies of the highest quality and efficiency in Latin America.

ServicesCRO + Full ServiceStrategic alliances and co-development projectsSpecialised consultancy in BiomedicineStrategic alliances and co-development projectsConsultancy in the Biomedical Sector

interest areas for future collaborationsDevelopment of clinical trials and settlement of biotech companies in the Canary Isles.Clinical studies and financing solutions for the development of molecules discovered by hospitals, universities and research centres.Undertaking drug and economic projects.Contact bridge between industry and research centres, universities and hospitals.

contactEd. Central Parque Tecnológico, Planta Baja, Oficina 11, Campus de Tafira3�017 Las Palmas - Spain

Tel: (+3�) 92 8�� 73 0�Fax: (+3�) 92 8�� 70 88http://www.dracenabioresearch.com

Queila delgadoBusiness Development Managerdracena@dracenabioresearch.com

31

company guide

2

Ebiointel, S.a.Sector: bio-information Technology

missionDevelopment of bio-IT platforms for the analysis of sequences, genetic diversity and genomic data in general in order to simplify and accelerate biomedical research.

productsEbioplatform: a bio-IT solution that integrates powerful analysis tools such as:

Sequence analysis: homologies, multiple alignments, motive searches, sequence assembly and quality estimates.Representation and analysis of genetic diversity: Analysis of SNPs (single nucleotid polymorphism), polymorphisms, bonding imbalances and association studies.Genomic data analysis.

ServicesEbiointel also offers the following services:

Genotype/ Phenotype association analysis services.Genetic population variation analysis services.Genome and sequence annotation analysis services.Personalised genetic analysis services.

interest areas for future collaborationsAlliances/Collaborations for development.Diagnostic chips through characterisation.Pharmacogenomics.Biological systems analysis.

contactEdifici M-Campus UABViver d’Empreses de Biotecnologia i Biomedicina (VE3B)-08193Bellaterra08193 Barcelona - Spain

Tel: (+3�) 93 �81 �6 3�Fax: (+3�) 93 �81 �6 36http://www.ebiointel.com

isabel duránManagerisabel.duran@ebiointel.com

Era7 information Technologies Sl (Era7)Sector: bioinformatics

missionTo help biotech companies and organizations in the biomedical field to take advantage of Information Technologies for a better information and knowledge management. With this objective in mind we design and provide advanced software solutions specially based on Internet technologies. Bioinformatics software development. Participation in R&D and innovation projects including participation in the EU VII Framework Program Agreements for marketing and distribution of our services and products.

productsPalinsight Pro : software for DNA palindromicity analysis and representation. Livera7 : Software specially designed to manage and held real time virtual Congresses and workshops.

ServicesServices of Knowledge Expression. Services of custom software development of Web applications, intranets, Web platforms and bioinformatics workflows automation. Bioinformatics and biosciences consultancy services.

contactBIC Granada, Av. de la Innovación 1Parque tecnológico Ciencias de la SaludArmilla. 18100 Granada - Spain

Tel: (+3�) 9� 87� 06 29Fax: (+3�) 9� 87� 06 29http://www.era7.com

eduardo parejaDirector Generalepareja@era7.com

32

EsteveSector: pharmaceutical industry

missionESTEVE is an R&D oriented company with a commitment to provide society with new therapeutic solutions with a high innovating value.

productsESTEVE’s activity lies in the pharmaceutical field, where it undertakes the research and development of new drugs in the area of prescription products, pharmaceutical advertising specialities, Vaccines, Hospital and Veterinary products, together with the production of drug active components.

contactAv. Mare de Déu de Montserrat, 221Barcelona080�1 Barcelona - Spain

Tel: (+3�) 93 ��6 60 00Fax: (+3�) 93 ��0 �8 99http://www.esteve.com

dr. eduard ValentíR&D Operations Managerevalenti@esteve.es

Eurogalenus Executive SearchSector: executive Search consultant

missionRecruitment, training, HR consultancy.Contribute to the identification and development of the best executives in the Biotechnology field.

ServicesSince 1992, recruitment of Board positions, non-executive Directors and senior Scientists. Experience in Biotechnology, Diagnostics, Devices, Electromedicine, Pharmaceuticals, Nutrition, Cosmetics, Veterinary, and their Service companies.

contactAvda. Alberto Alcocer, 7 Madrid28036 Madrid

Tel: 91 3�0 �� �6 / 7� 1�Fax: 91 3�0 7� 1�www.eurogalenus.com

luis TruchadoPartner-Directorluistru@eurogalenus.com

33

company guide

2

EurosemillasSector: agriculture, agrifoodstuffs industry

missionTo be a company of reference in the farming world, committed to agricultural development in the geographical areas where it is present.

productsSelect seeds.CottonGrain: cotton grain animal feed.Cotton fibre.Oleaginous oils.Development of licences for various plants:

Fruit trees.Strawberry.Citrus fruits.Raspberry.Others: avocado pears, asparagus, etc.

ServicesFarming news portal http://terraagraria.es.Development of an electronic commerce platform.

interest areas for future collaborationsSelect seeds.Genetic improvement.Biotechnology.Development of plant varieties.Farming portal.Extraction of vegetable oils and cotton fibre.

contactPaseo de la Victoria, 31 1º ACórdoba1�00� Córdoba - Spain

Tel: (+3�) 9� 7�2 17 32Fax: (+3�) 9� 7�2 20 92http://www.eurosemillas.com

José pellicerDevelopment Managereurosemillas@eurosemillas.com

fundación antama (The antama foundation)Sector: Transgenic products (biotechnology)

missionTo increase awareness about biotechnology and its applications in agriculture, the environment and food products.

ServicesCommunication, the organisation of events relating to biotechnology, cabinet for journalist consultations.

contactTravesía de Navaluenga nº 1, 107Majadahonda28020 Madrid - Spain

Tel: (+3�) 91 638 98 13Fax: (+3�) 91 63� 6� 69http://www.antama.es

elena fernández Guiral / alejandro GonzálezCommunication Manager / Assistantfguiral@fundacion-antama.org

3�

fundación parque científico de madrid (The madrid Science park foundation)Sector: rd&i

missionTo foster scientific research.

ServicesBusiness Development: Support for entrepreneurs, Business Creation, Business Incubator, Bioincubator, Access to financing, scientific and university environment.Scientific Services: Genomics, Proteomics, Micro-analysis of materials, Bio-IT, Biotransformations, Animal Health Care.

interest areas for future collaborationsThe creation of companies with a technological base.Science services to biotech companies.Large scientific facilities.Technical assistance for the creation and management of science and technology parks.

contactCtra. de Colmenar, km. 1�.Pabellón C, 1ª planta280�9 Madrid - Spain

Tel: (+3�) 91 �97 2� 00Fax: (+3�) 91 �97 2� 01http://www.fpcm.es

antonio r. díazGeneral Managerparque.cientifico@pcm.uam.es

gaikerSector: human health care, foods, environment and Services

missionGAIKER is an innovating centre in technologies relating to plastic materials and composites, the environment, recycling and the evaluation and industrial biotechnology available to companies.

ServicesOur range of products and services includes the undertaking of R&D projects, technological advisory services and assays and the certification of materials and products. This is complemented by the training we deliver, together with the organisation of communication activities and our technological documentation and surveillance services.

interest areas for future collaborationsGAIKER’s field of activity is the rendering of Technological Services and Innovation to companies, contributing to their technological development and their competitiveness through the generation, capturing, adaptation and transfer of innovating technologies in industrial biotechnology, plastics and their composites, the treatment and recuperation of contaminated waters and land, as well as industrial waste, recycling, reuse and revaluing of mass consumption waste.

contactParque Tecnológico. Edificio 202Zamudio�8170 Vizcaya - Spain

Tel: (+3�) 9� 600 23 23Fax: (+3�) 9� 600 23 2�http://www.gaiker.es

ignacio letonaGeneral Managermark@gaiker.es

3�

company guide

2

genetrix, S.l.Sector: biotechnology

missionGenetrix is one of a group of biotech companies specialised in the biomedicine area, born with the mission of fostering leading biopharmaceutical initiatives in the sector. The company’s main objective is to incorporate the outcomes of academic research into Medicine.

ServicesGenetrix is constantly working to bring together the outcomes arising from different scientific disciplines, by setting up and maintaining collaborations of a varied nature with public research centres, technological centres, public and private hospitals and pharmaceutical and biotech enterprises. This collaborative spirit is one of the features that most identifies the Genetrix Group’s and its has proven to be of great value in making this ambitious business project a reality. The Group is working on the creation of biotech initiatives assessing, designing and executing business plans in the life sciences field. The rapid evolution of the Genetrix Group is the direct result of the excellent quality of the work carried out by its professionals and the special concept held by its development team of the biotech business. The group’s speed of development is also underpinned by the selection of staff from a scientific and business background, in the keeping up of the links and collaboration with a variety of groups and the appointment of professionals of the highest level onto its management team.

interest areas for future collaborationBiotechnology.Life Sciences.Scientific applications for medical purposes.Investment in biotechnology.

contactMarconi, 1 Parque Tecnológico de MadridTres Cantos28760 Madrid - Spain

Tel: (+3�) 91 80� 92 6�Fax: (+3�) 91 80� 92 63http://www.genetrix.es

lourdes lapeñaFinancial Affairs Managerllapena@genetrix.es

genomica, S.a.u.Sector: human health care

missionTo offer experience and quality in all its products and services. To provide the health system with a tool for differential clinical molecular diagnosis applicable to infectious and oncogenic diseases. To be a reference centre in Spain for genetic identification tests, working under an accreditation frame provided by ENAC.

productsMolecular diagnostic kits focused on infectious and oncogenic diseases.

ServicesHuman DNA identification tests. Forensic Genetics technology transfer by “Turn key projects”: design, assembling of the laboratory, training of personnel, technical service and population database creation. Using genomics and proteomics tools, systems are being prepared to detect therapeutic activity in marine organisms for different diseases.

interest areas for future collaborationsIn licensing: Oncology molecular diagnostic systems. New molecular diagnostic technologies. Out licensing: Technology transfer and training in forensic genetics.

contactAlcarria nº 7 Edificio ZeltiaCoslada28820 Madrid - Spain

Tel: (+3�) 91 67� 89 90Fax: (+3�) 91 67� 89 91http://www.genomica.es

rosario cospedalGeneral Managerrcospedal@genomica.es

36

genzyme, S.l.Sector: human health care

missionThe discovery and development of innovating products and services for the treatment of serious pathologies, with special attention to rare diseases.Genzyme S.L. is the subsidiary of Genzime Corporation in Spain, dedicated to the development and introduction of therapeutic solutions for unresolved medical problems.

productsProducts on the market and under development at the following stages:

Lysosomal diseases: Cerezyme®, Fabrazyme®, Aldurazyme®.Renal insufficiency: Renagel®.Cancer: Thyrogen®.Transplants: Thymoglobulina®.Immunological disorders.Neurodegenerative diseases.Articular viscosupplementation: Synvisc®.Surgical adhesions: Seprafilm®.Biomaterials.

ServicesCell therapies

interest areas for future collaborationRare diseases/ orphan medical products.Renal insufficiency.Oncology.

contactDamián Sánchez López, 3 San Sebastián de los Reyes28700 Madrid - Spain

Tel: (+3�) 91 6�9 16 70Fax: (+3�) 91 6�9 68 62http://www.genzyme.com

fernando royoGeneral Managergenzymespain@genzyme.com

grifols Engineering, SaSector: biopharmaceutical engineering

missionThe company belongs to the Grifols holding and is specialized in engineering and consultancy services for the biotechnological and pharmaceutical fields.Grifols Engineering’s objective is to become the appropriate collaborator for the scale-up of the biotech field companies, from development phases to industrial production.

productsMachinery for biotechnological process: Fermentation, purification and aseptic filling Prototypes of machinery for biotechnological processes

ServicesServices of Biopharmaceutical Engineering and Consultany

interest areas for future collaborationBiotechnologyTechnological applications for medical purposes

contactCan Guasch, 2 Parets del VallesE-081�0 Barcelona - Spain

Tel: (+3�) 93 �71 03 93Fax: (+3�) 93 �71 03 93http://www.grifolsengineering.com

oriol argemiBusiness Unit Development Mg.oriol.argemi@grifols.com

37

company guide

2

grupo ZeltiaSector: chemical- biopharmaceutical

missionZELTIA is an outstanding reference in the improvement of well-being through the fight against cancer, nervous system degenerative diseases and other diseases. We have therefore taken up the challenge of pre-empting the future, and this is only possible through constant innovation, with an R&D policy that has positioned us as one of the top eight Spanish companies in R&D investment.

The companies comprising the Group:Pharmamar S.A, Neuropharma S.A, Genómica S.A.U, Xylazel S.A and Zelnova S.A.

ServicesThe discovery and development of drugs of marine origin, news, scientific publications.

interest areas for future collaborations:Zeltia: The third largest biotech group in terms of stock market capitalisation, the fourth Spanish company in R&D investment.

contactJosé Abascal, 2Madrid28002 Madrid - Spain

Tel: (+3�) 91 ��� �� 00www.zeltia.com

carmen eibeInstitutional Relations Managerceibe@zeltia.com

imbiosis, S.l.Sector: biotechnology

missionImbiosis, S.L. is a spin-off company, founded out of the Gluten Unit of the National Centre for Biotechnology (CNB), in which Genetrix, S.L. holds a 100% shareholding. It was founded with the commitment to develop new forms of food diagnostics, to assure the celiac community the supply of the only effective treatment for their disease: gluten-free food products. Imbiosis S.L. has set itself the target of becoming a leading biotech company in the analysis and traceability of gluten in foodstuffs.

productsExtraction Cocktail.

ServicesQuantitative techniques available:

ELISA R�.Competitive ELISA R�.

Qualitative techniques available:Western bolt.PCR RT.Maldi Tof.

interest areas for future collaborationFood diagnosis and traceability.

contactMarconi, 1Parque Tecnológico de MadridTres Cantos28760 Madrid - Spain

Tel: (+3�) 91 80� 92 6�Fax: (+3�) 91 80� 92 63www.imbiosis.com

loudes lapeñaFinancial Affairs Managerllapena@genetrix.es

38

indas BiotechSector: biotechnology

missionThe search for kits for diagnosis, prognosis and/ or response to cancer treatment, to cardiovascular and neurodegenerative diseases and others.Therapy with adult stem cells.Licence or sale of products resulting from research to interested companies.

productsHALOSPERM ®, a kit for the diagnosis of male fertility based on DNA fragmentation.F12 ®, kit for genetic risk of thrombosis.

contactCamino de las Huertas, 2 Edificio INDASPozuelo de AlarcónMadrid - Spain

Tel: (+3�) 91 �09 60 00Fax: (+3�) 91 71� 91 37

José-cándido arochena amestoyGeneral Managerjc_arochena@indas.es

inmunología y genetica aplicada, S.a. ingEnaSaSector: biotechnology in animal health care

missionResearch, development, production and commercialisation of biotech products for animal health care.

productsSerologic diagnosis assays.Molecular diagnosis assays.Second generation vaccines.

Services Protein expression, monoclonal antibodies.

contactHermanos García Noblejas, 39. 8ºMadrid28037 Madrid - Spain

Tel: (+3�) 91 368 0� 01Fax: (+3�) 91 �08 7� 98http://www.ingenasa.es

carmen Vela olmoGeneral Managercvela@ingenasa.es

39

company guide

2

instituto Biomar, S.l.Sector: human health care

missionThe discovery of new drugs of natural origin.

productsMicrobial marine extracts.Compounds of scientific or industrial interest, of microbial origin.

ServicesFermentation.Chemistry of natural products.Bioassays.Research programmes.

interest areas for future collaborationsPharmaceutical and agrifoodstuff companies interested in the search for new bioactive principles of marine microbial origin. The company offers classified marine bacterial extracts, the undertaking of assays, fractioning, purification and structural elucidation of the active compounds. Production, up to kilos, of these for development studies.

contactEdificio CEEI Polígono Industrial Onzonilla2�231 León - Spain

Tel: (+3�) 98 78� 92 00 Fax: (+3�) 98 78� 92 03 http://www.institutobiomar.com

agustín pérez-arandaGeneral Manageragustin@institutobiomar.com

instituto de Salud carlos iiiSector: Government

missionA public research body belonging to the Spanish Ministry of Health and Consumption, whose mission is to foster, develop and render technical scientific services in the field of human health care.

ServicesResearch into the different aspects relating to the application of genetic knowledge in diagnosis, therapy, the development of new drugs and epidemiology.The development of innovation in telematics, bio-IT, genomics and proteomics and other new technologies applied to health care.The conservation of international standards and the preparation and conservation of national standards.Awarding aid and subsidies for biomedical research.Drawing up reports about healthcare technologies and services aimed at consolidating decision-making at the different levels of the National Healthcare System.

interest areas for future collaborationMolecular Diagnosis.Telematics and Bio-IT.Proteomics and genomics.Healthcare technologies.

contactSinesio Delgado, 6Madrid28029 Madrid - Spain

Tel: (+3�) 91 822 20 00Fax: (+3�) 91 387 78 30http://www.isciii.es

Julia medrano chiviteOTRI SG Service Chief for international Research Programmes and Institutional Relations

otri@isciii.es

�0

instituto universitario de ciencia y Technology, S.a. (iucT)Sector: research and development

missionTo develop innovating processes and products for the chemical, pharmaceutical and biotech industry sectors.

ServicesResearch, Development and Innovation projects.Contract research or customised RD&I projects.Development of its own RD&I projects to transfer the final outcomes to industry.Development of its own technological platforms, available for use on industrial projects.Technological services: Analysis and consultancy.Analysis services in different scientific areas.Consultancy services in technical areas.Transmission of knowledge and specialised training.Open and customised training in broad areas of scientific knowledge.Conferences, seminars, workshops and congresses.

interest areas for future collaborationThe pharmaceutical and biopharmaceutical industry.The chemical and fine chemical industry.The food sector.The environment / health at work.

contactAlvarez de Castro, 63Mollet08100 Barcelona - Spain

Tel: (+3�) 93 �79 3� 32Fax: (+3�) 93 �70 �7 ��http://www.iuct.com

angeles molinaManager of the Business Projects Dept.

iuct.sales@iuct.com

�1

company guide

2

integromics, S.l.Sector: bio information Technology.

missionTo provide the market with up to date knowledge on IT solutions in the field of life sciences and particularly in genomics and proteomics.

ServicesThe development and marketing of software for genomic and proteomic data management, analysis and mining.Professional services relating to these products.

interest areas for future collaborationsThe development and commercialisation of software for genomics, proteomics and related sectors

contactAvenida de la Innovación, 1Armilla18100 Granada - Spain

Tel: (+3�) 9� 87� 06 27Fax: (+3�) 9� 87� 06 27http://www.integromics.com

Vicente rodríguez Administratorvicente.rodriguez@integromics.com

Juste, S.a.Q.f.Sector: pharmaceutical industry

missionJUSTE, S.A.Q.F. is a company which researches, develops and distributes pharmaceutical products. JUSTE also has an outstanding R+D and industrial activity related to the generation and manufacture of soft-gel capsules.

productsThe Therapeutics Division commercializes prescription drugs for the three following Areas: Primary Care, Women’s Health Care and Central Nervous System.The Hospital Division remains dedicated to the diagnosis within the radiology field. JUSTE has diversified its hospital diagnosis line taking part and acquiring new projects and products which incorporate innovative technologies on diagnosis, oncology and anesthesia.

interest areas for future collaborationJUSTE maintains a continual interest in collaborating on development projects as well in establishing License agreements (exclusive licenses, co-marketing and/or co-promotion agreements) for Spain, Portugal, Central America and South America countries in the following therapeutic areas Primary Care, Women’s Health Care and Central Nervous System and products for diagnosis and treatment aimed at hospitals. JUSTE is aware of the advances in biotechnology and considers very important the use of genetics for a personalized medicine. JUSTE commits itself in the innovative biotechnology industry with new products for clinical diagnosis.

contactJ. Ignacio Luca de Tena, 828027 Madrid - Spain

Tel: (+3�) 91 72� 82 00Fax: (+3�) 91 72� 82 0�http://www.juste.com

charo Guinea Business Development

roguinea@juste.net

�2

laboratorios calier, S.a.Sector: animal health care

missionResearch, development and commercialisation of veterinary products aimed at production animals, together with specialised products aimed at pets and a select range for horses.A company producing raw materials and finished products for the Animal Healthcare market, our activity comprises the research, development, production and commercialisation in 70 countries of generic products, licences and its own know-how, including those lying in the immunological, pharmacological, nutritional and biocide fields. The two vertical biotechnology lines are the extraction and purification of matrix proteins and biological fluids and the production and extraction of heterologous proteins of immunological or pharmaceutical interest. Both lines are oriented towards obtaining hormone and immunological products.

productsPharmacological pharmaceutical specialities.Immunological pharmaceutical specialities.Animal care, hygiene and handling products.Biocides.Animal food additives.

ServicesAutovaccines, diagnostics and eradication programmes.

Aspects linked to biotechnology:The production of antigens and proteins produced by heterologuos systems, in order to obtain products for:

Diagnosis, control and prophylaxis.Vaccine products with detectable vaccine antigens.Hormone products for synchronisation of animals coming into heat and ovulation induction.

interest areas for future collaborationGeneral immunology.Animal reproduction.Expression systems of heterologous recombinant proteins.

contactBarcelonés 26 Pla del RamassàLes Franqueses del Vallès08�20 Barcelona - Spain

Tel: (+3�) 93 8�9 �1 33Fax: (+3�) 93 8�0 13 98http://www.calier.es

Joan marca y puigResearch and Development Manager

r-d@calier.es

laboratorios lETi, SlSector: pharmaceutical industry

missionHuman Health Care / Therapy.A pharmaceutical laboratory specialised in immunology and preventive medicine, diagnostic products and self-health care.

productsAllergy: Diagnoses, allergen extracts for treatment, bacterial treatments, environment control, allergens.Diagnostics: Fast and molecular biology diagnostics for infectious diseases.Personal care: LETI AT-�, Urea LETI, Sebamed, Letibalm, Letitest, etc.Vaccines: Antitetanus; Anti Diptheria-tetanus-pertussis – DTP; LETI polyspecific influenza vaccine.Veterinary Diagnosis: LetQTest.

contactGran Via de les Corts Catalanes, 18�. 7º 1ªBarcelona08038 Barcelona - Spain

Tel: (+3�) 93 39� �3 �0 Fax: (+3�) 93 332 9� 60http://www.leti.com

Gloria roéManager of the Diagnosis and Vaccines Business

groe@leti.com

�3

company guide

2

laboratorios lillySector: human health care

missionTo develop and foster medicines that enable us to have healthier and more active lives, treating diseases like depression, schizophrenia, cancer, osteoporosis, erectile disorder and many others.

productsCardiology: ReoPro.Growth: Humatrope.Intensive Care: Xigris.Diabetes: Actos, Humalog, Humulina.Oncology: Gemzar.Parkinson’s Disease: Pharken.Psychiatry: Prozac, Zyprexa.Women’s Health Care: Evista.Urology: Cialis.

contactAvda. de la Industria, 30Alcobendas28108 Madrid - Spain

Tel: (+3�) 91 663 �0 00Fax: (+3�) 91 663 �2 31www.lilly.es

Juan carlos GómezClinical Research Managergomez_juan-carlos@lilly.com

laboratorios ovejero, S.a.Sector: Veterinary pharmaceutical (animal health care)

missionThe development, manufacturing and commercialisation of pharmaceutical and veterinary products.

productsContract Manufacturing.

interest areas for future collaborationsDevelopment of Immunological Products.

contactCtra. León a Vilecha 30León2�192 León - Spain

Tel: (+3�) 90 223 �7 00Fax: (+3�) 98 720 �3 20http://www.labovejero.com

Juan pablo ovejeroGeneral Managergerencia@labovejero.es

��

merck farma y QuímicaSector: pharmaceutical and chemical

missionResearch and attainment of high quality innovations in pharmaceutical products and chemical products, concentrating our activities on business sectors where we achieve competitive advantages thanks to the excellent quality of out products, services and systems.

productsPharma

Drugs: for cardiology and thyroid disorders, diabetes, oncology, female health care, respiratory tract complaints and allergies.Generic medicines.Consumer Health Care: Vitamins and minerals, cold products, natural medicines, dietetic products.

ChemistryLiquid Crystals: components for liquid crystal screens.Pigments.Reagents and products for analysis.Life Science Products: Raw materials, excipients and active principles for the pharmaceutical and biotech industry.

contactPolígono Merck s/nMollet del Vallés08100 - Spain

Tel: (+3�) 93 �6� �� 00Fax: (+3�) 93 ��� 00 00http://www.merck.es

alberto buenoGeneral Managementcomunicacion@merck.es

merck- Serono España, S.a.Sector: biotechnological pharmaceuticals

missionLeadership in the business areas in which it is present, as well as being a reference in the group as a biotech production centre.

productsProduction and commercialisation of recombinant products in the following therapeutic areas: Reproductive health, neurology, metabolism and dermatology.

interest areas for future collaborationsOncology.

contactMaria de Molina, �0Madrid28006 Madrid - Spain

Tel: (+3�) 91 7�� �� 00Fax: (+3�) 91 7�� �� 31http://www.serono.com

laura González moleroGroup Vicepresident and General Manager de Serono España

laura.gonzalez@serono.com

��

company guide

2

merck, Sharp & Dohme de España, S.a.Sector: chemical

missionThe research, development, commercialisation and manufacturing of innovating medicines.

productsMedicines.

interest areas for future collaborationsDevelopment and research of therapeutic targets.

contactJosefa Valcárcel, 38Madrid28027 Madrid - Spain

Tel: (+3�) 91 321 06 78Fax: (+3�) 91 321 08 �9http://www.msd.es

regina revillaManager for External Relations and Communication

regina_revilla@merck.com

miltenyi BiotecSector: health & cell Therapy

missionMiltenyi Biotec develops, produces, and markets state-of-the-art products and services for cell separation, cell analysis, cell culture, molecular biology, and clinical research applications.

productsMACS® Technology for Cell Separation AutoMACS™ CliniMACS® Microarrays & Bioinformatics Adsorbers for Therapeutic Apheresis

contactLuis Buñuel nº 2Ciudad de la ImagenPozuelo de Alarcón28223 Madrid - Spain

Tel: (+3�) 91 �12 12 90Fax: (+3�) 91 �12 12 91www.miltenyibiotec.com

ivan alvarez-SierraCountry Managermacs@miltenyibiotec.es

�6

monsanto agricultura España, S.l.Sector: agriculture

missionTo attend the world’s food needs.To conserve natural resources.To protect the environment.To serve our customers and our shareholders.

productsMonsanto is a group of companies whose activity is aimed at the development and improvement of agriculture and the food sector. For over one hundred years Monsanto has been researching, developing and commercialising services for the farming sector and it has concentrated its aims on providing sustainable agricultural systems, beneficial for farmers all over the world.Monsanto is committed to developing safe technologies and products that are beneficial for both farmers and consumers.Our most outstanding products are our herbicides from the Roundup range and the Dekalb brand seeds. For further information on our products go to: http://monsanto.es/monsantoes/productos.html.

interest areas for future collaborationsPlant Biotechnology.Conservation farming.Biofuels.

contactAvenida de Burgos, 17Madrid2803� Madrid - Spain

Tel: (+3�) 91 3�3 27 01Fax: (+3�) 91 3�3 27 27http://www.monsanto.es

rosa morenoCommunication Managerrosa.m.moreno@monsanto.com

natraceutical groupSector: biotechnology

missionTo be leader in the functional foodstuffs sector through the innovation, development and production of healthy ingredients and support services for our customers to obtain optimal market performance from the products developed.

our visionTo offer functional ingredients and value adding services through:

Comprehensive product development ( from the birth of the idea to market launch).Clinical validation of its healthy imbuing properties.Customer and market focus.Continued quality guarantee.Professional training and development of our staff.

productsNatraceutical specialises in the research, development and commercialisation of functional ingredients and health imbuing natural compounds aimed at the food, cosmetics and pharmacy sectors.

interest areas for future collaborationsInnovation and development of functional ingredients for the food, cosmetics and pharmacy sectors.

contactPlaza América, 2. 9ª planta�600� ValenciaSpain

Tel: (+3�) 96 192 08 �1Fax: (+3�) 96 33� 32 ��http://www.natraceuticalgroup.com

Zachary SnidermanMarketing Assistantinfo@natraceuticals.com

�7

company guide

2

neocodex, S.l.Sector: biomedical research

missionNeoCodex is a biomedical and genomic research company focused on understanding the molecular and genetic basis of human disease.

productsSuccessful in engineering and housing Spain’s largest databank of DNA samples, NeoCodex has created a nationwide cooperative of hospital systems, working together to build a fully-annotated network of samples from common disease states present within the uniquely homogenous population of Spain (www.neocodex.com).With broad capabilities, spanning the oeuvre of scientific project design, Neocodex has developed an extensive range of available services ranging from full contract completion to supplementary additions and venture execution.

ServicesWith broad capabilities, spanning the oeuvre of scientific project design, Neocodex has developed an extensive range of available services ranging from full contract completion to supplementary additions and venture execution.

interest areas for future collaborationsHFCC presents clients with a revolutionary new way of conducting whole genome association studies. The innovation behind the advancement lies in the ability to use smaller sample sets from various disease states of interest, whereby a common patho-physiological state exists.

contactCharles Darwin 6 AccASevilla�1092 Sevilla - Spain

Tel: (+3�) 9� �0� 76 18Fax: (+3�) 9� �0� 73 2�http://www.neocodex.com

rocío pascualAssistantrpascual@neocodex.es

neuropharma, S.a.Sector: chemical-pharmaceutical-biotechnological

missionThe development of medicines for the treatment of diseases of the CNS.

productsMolecules under research against neurodegenerative diseases, mainly Alzheimer’s Disease. Phase I clinical studies have begun with the first molecule in our pipeline.

interest areas for future collaborationsWithin our collaborations policy, Neuropharma maintains relations with numerous public and private sector research institutions, to advance in the development of our molecules and for the research into new ones against neurodegenerative diseases.The company is interested in setting up new collaborations with research centres that will lead to an enhancement of our activities in the field of neurosciences.

contactAvda. de la Industria, �2Tres Cantos28760 Madrid - Spain

Tel: (+3�) 91 806 11 30Fax: (+3�) 91 803 �6 60http://www.neuropharma.es

mercedes rodríguez barreraBusiness Development Managermrodriguez@neuropharma.es

�8

newbiotechnic, S.a.Sector: rd&i, farming and agrifoodstuff biotechnology

missionTo identify, protect and commercialise microbiological and molecular tools with an immediate, practical application in the farming and agrifoodstuffs sector, which are safer for the consumer and more respectful with the environment.Founded in 1999, NBT is an R&D company in farming and agrifoodstuff biotechnology, with three business areas:1) Biological control agents 2) Gene technology for improving crops, and 3) Molecular diagnostics services. It has genomics and phytopathology laboratories and a pre-industrial production plant and a HR team, including six people with Ph.D’s. With a technological portfolio of over 20 patents and a research network of �� groups at world level, NBT is a pioneer in the development and registration of biofungicides and leader in molecular phytopathology.

productsBiological Control Agents (biofungicides, bioinsecticides).Tools for plant improvement by genetic trnsformation.

ServicesGenomic and Bio-IT services.Phytopathological diagnostics.Agrifoodstuff diagnostics.Veterinary diagnostics.Human genetic diagnostics.

interest areas for future collaborationsThe development of microbiological products for crop protection. Submerged fermentation technology and product recuperation.Co-development/ distribution of natural products for agriculture (microbiological products, plant extracts, organic extracts, etc.).Development of diagnostic genetic tests for farming, aquaculture, veterinary and food product applications.The development of concept tests in plant genetic transformation.

contactPaseo de Bollullos de la Mitación, 6PIBO - Bollullos de la Mitación�1110 Sevilla - Spain

Tel: (+3�) 9� �77 67 10Fax: (+3�) 9� �77 67 11www.newbiotechnic.com

manuel reyGeneral Managermrey@nbt.com

�9

company guide

2

noray Bioinformatics, S.l.Sector: bio- information Technology

missionTo serve as a support in information technologies to the biosciences sector, especially in the design, development and implementation of customised software.

productsNoraymet: Biopharmacy line for ADME studies.Cacoready SoftwareTM.Noraymet: ADMETM.Noraygen: Genomics Line.BITIA: Correlation of genetic and clinical data on cancer.Genoplat: LIMS platform for genotyping.Noraygen: Gene expression.Norayprot: Proteomics Line.Proteomics LIMS.Denimprot.Noraytools: Line of software products for information management in biosciences.Fivisoft: Assisted fertility clinics.Viogen: Plant bioprospection.Biobanks: management of information on cell, tissue, DNA and micro-organism banks.Animal Houses.

interest areas for future collaborationsMetabolomics, pharmacogenomics, neurogenomics.

contactParque Tecnológico, 801 ADerio�8160 Vizcaya - Spain

Tel: (+3�) 9� �03 69 98Fax: (+3�) 9� �03 69 99http://www.noraybio.com

Julio fontGeneral Managerfont@noraybio.com

operon, S.a.Sector: in Vitro diagnostics

missionTo be international leader in 6 technologies relating to In Vitro Diagnosis: Monoclonal antibodies, recombinant antigens, agglutination latex, immunochromotography, ELISA and Molecular Biology tests.

ServicesResearch, development and manufacturing of Monoclonal Antibodies.Research, development and manufacturing of Recombinant Antigens.RD&I and manufacturing of In Vitro Diagnostic kits based on immunological reactions.RD&I and manufacturing of In Vitro Diagnostic kits based on molecular biology.

interest areas for future collaborationsIndustrial production and purification of monoclonal antibodies and recombinant antigens.Design and large scale production or with own brand of new In Vitro Diagnostic tests.

contactCamino del Plano, 19Cuarte de Huerva�0�10 Zaragoza - Spain

Tel: (+3�) 97 6�0 3� 97Fax: (+3�)97 6�0 3� 31http://www.operon.es

Tomás ToribioGeneral ManagerInfo@operon.es

�0

oryzon genomicsSector: biotechnology

missionThe activity of Oryzon Genomics consists of identifying, obtaining and manipulating genes through new genomic, proteomic and bio-IT techniques, which enable developments to be executed and biotech products to be designed that improve people’s health.

ServicesOryzon’s activity concentrates especially on the identification of biomarkers which enable an early diagnosis to be made of serious diseases such as oncological or neurodegenerative diseases, and which support the clinical professional in establishing a prognosis and the identification of potential new therapeutic targets which may be used as the starting point for identifying and developing new drugs.Oryzon also undertakes this activity in the plant field in order to produce new plant varieties with improved nutritional properties by enriching the compounds which contribute to prophylaxis and to consumer health (functional foods).

contactJosep Samitier, 1-�Barcelona08028 Barcelona - Spain

Tel: (+3�) 93 �03 71 96Fax: (+3�) 93 �03 �7 92 http://www.oryzon.com

carlos buesaCEOinfo@oryzon.com

palau pharmaSector: biopharmaceutical

missionTo discover and develop alone or in collaboration with our strategic partners novel, patent-protected pharmaceuticals for the treatment of inflammatory or autoimmune conditions.

ServicesThe projects developed by our partners are:, Albaconazole: Oral and topical antifungal agent, p38 MAP kinase inhibitor: Anti-inflammatory agent, Cimicoxib: Cyclooxygenase-2 inhibitor for veterinary use, Cimicoxib: Cyclooxygenase-2 inhibitor for CNS indications, Triflusal-Stents: Drug eluting coronary stent coated with a polymer containing the drugs triflusal and simvastatin

interest areas for future collaborationsIn-licensing: outlicensing, compounds Phase I clinical trials, therapeutic fields allergic and autoimmune origin.Out-licensing: we are building an exciting and attractive pipeline with several projects at various stages of development. We are also open to the possibility of establishing partnerships and collaborative agreements at earlier stages of development

contactAvinguda Camí Reial �1-�7Polígono Industrial Riera de Caldes Palau-solità i Plegamans 0818� Barcelona - Spain

Tel: (+3�) 93 86� 96 92Fax: (+3�) 93 86� 66 06http://www.palaupharma.com

lydia Sanmartí Vilalsanmarti@palaupharma.com

company guide

2

parc científic de Barcelona (Barcelona Science park)Sector: cell and development biology

missionThe Parc Científic de Barcelona (PCB) is a pioneer innovation system created by the University of Barcelona, which incorporates public research groups and companies on a single 22,000 square-metre site with powerful services and Biotech Platforms for supporting RD&I.The PCB has been fully operational since its inauguration in 2001 and its aim is to boost quality research, to foster knowledge and technology transfer and to facilitate the creation of new, technology-based companies.

ServicesIt houses twenty companies, three research centres and the CIDEM-PCB Bio-incubator, which undertake their activity in the rising areas of chemical, pharmaceutical and biotech research as well as nano-bioengineering.These areas have a wide of technological services at their disposition (www.pcb.ub.es/servicios), focused on:

Biotechnological Platforms.SCT-UB Scientific and Technical Services.PCB Scientific Services.

interest areas for future collaborationsThe Institut de Recerca Biomèdica de Barcelona, the IRBB-PCB, (The Barcelona Biomedical Research Institute) is the largest research centre in the PCB. It concentrates 1� excellence groups from the University of Barcelona and the ICREA programme, and around 100 researchers from the CSIC Barcelona Molecular Biology Institute. The IRBB-PCB is organised into � research programmes: The Cell Biology and Development Programme, The Structural and Computational Biology Programme, The Molecular Medicine Programme and the Chemical and Molecular Pharmacology Programme.

contactCampus Diagonal Universitat de BarcelonaBaldiri Reixac, 10-12 08028 Barcelona - Spain

Tel: (+3�) 93 �02 90 60Fax: (+3�) 93 �02 90 63http://www.pcb.ub.es

Sonia martínez arcaScience Area Managersmartinez@pcb.ub.es

pevesa, S.l.Sector: bioagriculture, nutraceutics and foodstuffs, industrial fermentations, biopharmacy

missionTo be a reference in the design, production and R&D in the area of proteins, peptics and amino-acids and biochemical compounds employing biotechnology as a work tool.

productsProteins, peptics, biochemical products.

ServicesIndustrial Biotechnology and Biochemical Engineering.Enzyme and Fermentation Technology.RD&I Laboratories and Pilot plant.

interest areas for future collaborationsContract manufacturing, custom made manufacturing.Product development.Collaboration, research and development agreements for new products.Joint Ventures.Investment in biotech projects.

contactPolígono Industrial PolivisoAvda. de la Industria s/nEl Viso del Alcor�1�20 Sevilla - Spain

Tel: (+3�) 9� �9� 60 2�Fax: (+3�) 9� �9� �6 20www.pevesa.es

iñaki mielgoGeneral Manager and CEOimielgo@pevesa.es

�1

�2

pharmamar, S.a.u.Sector: biopharmaceutical

missionThe discovery and development of marine origin, anti-cancer drugs.

productsA portfolio of marine origin compounds at various stages of clinical development, which include Yondelis®, Aplidin®, ES-28�, Kahalalido-F, Zalipsis® and PM0273�.

interest areas for future collaborationsInterest in setting up collaborations for the discovery and clinical development of small molecules with anti-cancerous activity an in new approaches to cancer treatment.

contactPoligono Industrial La Mina Avda. de los Reyes, 1 Colmenar Viejo28770 Madrid - Spain

Tel: (+3�) 91 8�6 60 00Fax: (+3�) 91 8�6 60 01http://www.pharmamar.com

ana benavidesBusiness Development Managerabenavides@pharmamar.com

pioneer hi-Bred Spain, S.l.Sector: agricultural seeds, farming

missionThe development, production and commercialisation of agricultural seeds and inoculants for the conservation of animal fodder.

productsMaize, Sorghum, sunflower, cotton, soybean, corn, lucerne, rape seeds.Lactic bacteria inoculants for animal fodder conservation.

ServicesComprehensive agronomic services of complete advisory service to agricultural users of the plant species marketed.

interest areas for future collaborationsThe development of varieties of plant species and inoculants for agriculture and stock farming.Development of methods and knowledge concerning stock feeding.Development of varieties of plant species for human nutritional use.Development of varieties and processes for the bio-energy industry.Development of processes for improving and knowing the agricultural crop environment better (soils, waters, efficiency and irrigation methods, abiotic factors, pest control, etc.).

contactAvda. Reino Unido s/nEdificio ADYTEC - Euroficinas 2ª Planta�1012 Sevilla - Spain

Tel: (+3�) 9� �29 83 00Fax: (+3�) 9� �29 83 �0http://www.pioneer.com

alberto ojembarrenaOperations Manageralberto.ojembarrena@pioneer.com

company guide

2

Sabiobbi, S.l.Sector: biotechnology, human health

missionBiotechnology. Human health.

ServiceWe are a company dedicated to the marketing, distribution and research of products and services related to Human Health. Our aim is to achieve a personalized medicine using treatments based on biotechnologic diagnosis.

productsGenetic tests through DNA microarrays (biochips) that allow:

to prevent risks associated with age-related diseases (AgingChip). to measure our physical and metabolic capacity, assessing the potential of response to physical training (SportChip). to guide on the criteria to be followed in connection with our habits and way of life (QualityChip).

contactEnrique Jardiel Poncela, � - 2ºMadrid28016 Madrid - Spain

Tel: (+3�) 91 3�3 01 89Fax: (+3�) 91 3�3 01 90http://www.sabiobbi.com

Silvia cruzTechnician Managersabiobbi@sabiobbi.com

Seaweed canariasSector: marine biotechnology

missionTo develop and supply our customers with all-round, sustainable, advanced technology solutions, through the industrial application of active principles from seaweeds.

productsAlgaCanTM: A range of ecological biostimulants for agriculture, based on a unique combination of macro and micro seaweeds.Functional food compounds enriched with natural ingredients exclusive to seaweeds.Cosmetic products based on active principles from seaweeds such as antioxidants and skin firming products.

interest areas for future collaborationsInnovation and development of innovating food products that contain nutritional elements and properties exclusive to seaweeds.Development of R&D activities relating to sewage disposal through the application of seaweed’s biofiltering properties.Development of innovating products for animal feeds based on the immuno-modulating and prebiotic properties derived from seaweeds.

contactFuente, 7Las Palmas de Gran Canaria3�001 Las Palmas - Spain

Tel: 92 838 2� 2�Fax: 92 837 3� 06http://www.seaweedcanarias.comhttp://www.algacan.com

Sergio cáceres/ alberto dumasInstitutional Relations Manager/ Commercial managerscaceres@seaweedcanarias.comadumas@seaweedcanarias.com

�3

��

Sensia, S.l.Sector: biotechnology

missionSensia is the first Spanish Initiative to set up a leading company in the instrumentation sector for life science research laboratories and for environment measurement.Sensia develops and commercialises portable, mulitbiosensor systems, based on technologies developed by the Biosensors Group of the National Microelectronics Centre, belonging to the Higher Council for Scientific Research.

productsSENSIA 2-SPR is an instrument based on Surface Plasmon Resonance (SPR) which enables comparative measurements to be made by incorporating channels. It also includes computer-controlled pumps and microfluid valves for sample injection. The Surface Plasmon resonance is a powerful technology for measuring biomolecular interactions, allowing real-time measurements without having to brand the analytes. The 2-SPR system has a large number of applications; in general all those studies based on biomolecular interactions: biochemical and chemical detection, discovery of medicines, diagnostics, proteomics, genomics, forensic medicine, food analysis, environmental monitoring, etc.

interest areas for future collaborationsThe development of biosensors and their components.The development of new biosensor applications.Basic and clinical research.Diagnostic applications.

contactMarconi, 1Parque Tecnológico de MadridTres Cantos28760 Madrid - Spain

Tel: (+3�) 91 80� 92 6�Fax: (+3�) 91 80� 92 63http://www.sensia.es

lourdes lapeñaFinancial Affairs Managerllapena@genetrix.es

Sigma aldrich Química, S.a.Sector: Supplies

missionWe are committed to our customers, employees and shareholders’ success through science, technology and service.

productsReagents, chemical and biological products, laboratory kits and supplies for scientific life science research, biotechnology and high technology chemistry and for pharmaceutical and chemical development and manufacturing.Services.Customised development and synthesis of chemical and biological products, scale increases.

contactRonda de Poniente 3, 2ª planta Apdo. correos 278. Tres Cantos28760 Madrid - Spain

Tel: (+3�) 90 010 13 76 Fax: (+3�) 90 010 20 28http://www.sigmaaldrich.com

manuel morenoGeneral Managermmoreno@eurnotes.sial.com

��

��

company guide

2

Sistemas genómicos, S.l.Sector: Sistemas Genómicos is a biotech company specialised in genetic diagnostics and genomic research

missionThe company’s main aims are the research, development and commercialisation of analytical applications based on genomics technology. The company’s activity is concentrated on the development of analytical methods capable of satisfying the needs of the agrifoodstuff and pharmaceutical industry, hospitals and research centres.

productsKit AutentiGen® GMOscreen, Mammals, Salmonella and BirdsKit ExtraGen® Foods and Animal Feeds

ServicesSequencing: DNA Sequencing ServiceBiomedicine: Genetic-Molecular Studies, Cytogenetic Studies, Reproductive Genetics StudiesAgrogenomics: GMO Analysis Service, Gluten Detection Service, Allergen Detection Service, Fast Pathogen Detection Service, Genetic Authentication of foodstuffsEnvironment Quality: Rapid Legionella Detection ServiceResearch: Agrogenomics, Biomedicine (diagnostics and pharmacogenetics), Genomic Technology, Industrial Biotechnology, Animal Health CareOther Business Lines: Genome Projects,Bio-IT, Transcriptomics, Research Support Services, Traceability

interest areas for future collaborationsThe company develops and commercialises customised services, products and R&D projects in the following fields:

The company develops and commercialises customised services, products and R&D projects in the following fields: Agrifoodstuffs, Human Health Care, Animal Health Care and Genomics.

contactParque Tecnológico de Valencia Ronda G. Marconi, 6Paterna�6980 Valencia - Spain

Tel: (+3�) 90 236 �6 69Fax: (+3�) 90 236 �6 70http://www.sistemasgenomicos.com

ana martínez hortiguela Marketing and Sales Manager

anam.hortiguela@sistemasgenomicos.com

Suan farma, S.a.Sector: pharmaceutical

missionTo provide manufacturing services for third parties.Co-participation/ investment as industrial partners in the development of biotechnology projects.

productscGMP manufacturing of proteins in our partner organisation Angel Biotechnolgoy Ltd. (Newcastle, UK): Biopolymers, enzymes, monoclonal antibodies, vaccines, A protein, biogeneric products, etc.cGMP manufacturing of cell cultures: Stem cells, whole cells, etc.

ServicesConsultancy and financing search for biotechnology projects.

interest areas for future collaborationsBiopolymers and bio-remediation.Cell therapies.Therapeutic protein development and manufacturing.Search for investors and partners for biotechnology projects.

contactIsabel Colbrand 10, Oficina 113Madrid280�0 Madrid - Spain

Tel: (+3�) 91 3�� 68 90Fax: (+3�) 91 3�� 68 9�http://www.suanfarma.com

Javier fernándezArea Managerjavierfernandez@suanfarma.com

�6

SylentisSector: biotechnology

missionBiotech and therapeutic applications in interference RNA technology.

contactJosé Abascal nº 2Madrid28003 Madrid - Spain

Tel: (+3�) 91 823 �� �3Fax: (+3�) 91 8�6 60 01http://www.sylentis.com

ana isabel JiménezR&D Directoraijimenez@sylentis.com

universidad autónoma de Barcelona (The autonomous university of Barcelona)Sector: people with an entrepreneurial spirit who form part of the uab: lecturers, researchers, students, alum-ni, administration and services staff and other people linked to the uab

missionTo foster the entrepreneurial spirit within the UAB. To foster the creation of an entrepreneurial centre in order to attract innovating projects from entrepreneurs within the sphere of the UAB in their most embryonic stages and to support them during their creation period until they become competitive companies going on to form part of Catalonia’s business fabric.

productsTo support the execution of business plans from UAB entrepreneurs. Personal accompaniment and coaching. Specific training in the area of entrepreneurship. Seeking financing for business initiatives. To support project viability during the established creation period. Consolidation of human capital and setting up of strategic alliances. Management and co-ordination of UAB company nurseries:

Masía Can Fatjó – PTV, UAB Company Nursery.Biotechnology and Biomedicine to Biocampus Company Nursery (VE3B).Partner Centre Nurseries:

National Microelectronics Centre. Computer Viewing Centre.Artificial Intelligence Research Institute.Matas, an economic interest group based on research into materials and gases.Internationalisation and networking.

contactCampus de la UAB - Edificio ABellaterra (Cerdanyola del Vallés)08193 Barcelona - Spain

Tel: (+3�) 93 �81 �2 3�Fax: (+3�) 93 �81 20 23http://www.uab.es

Sónia GonzálezBusiness Creation and Innovation Office Manager

innovacio.creacio@uab.es

universidad de navarra (navarre university)Sector: higher education, research and health care

missionHigher education, basic and applied research and specialised medical attention.

contactCampus Universitario s/nPamplona31080 Navarra - Spain

Tel: (+3�) 9� 8�2 �6 00Fax: (+3�) 9� 8�2 �6 19http://www.unav.es

José manuel Zumaquero/ maría fontLegal Representative/ Person for Scientific Contactsjmzumaquero@unav.es

�7

company guide

2

veterindustriaSector: animal health care

missionTo defend the collective interests of the associated companies that manufacture and/ or commercialise the following products and services in Spain: Veterinary medicines, animal healthcare and nutritional products and additives for animal nutrition, through its different co-ordination, advisory and communication services, to thus promote all the aspects of the Animal Healthcare and Nutrition Industry, benefiting both the sector and society in general.

ServicesTo foster the maintenance of the highest levels of effectiveness, quality and safety in their Animal Healthcare and Nutritional Products, Veterinary Medicines and Additives for Animal Nutrition, within the strictest norms of professional ethics and in accordance with the code of fair practice.To set up communication channels with all spheres of society to increase awareness of the importance of the Animal Healthcare and Nutrition Industry, together with its contribution to the improvement in the quality of life both for animals and for people.

contactFernanflor 8, 1-AMadrid2801� Madrid - Spain

Tel: (+3�) 91 369 21 3�Fax: (+3�)91 369 39 67http://www.veterindustria.com

Santiago de andrésDirector Generalveterindustria@veterindustria.com

vircell, S.l.Sector: human health care

missionTo produce quality reagents and to develop innovating products that imply significant advances.

productsCell Culture: Cell lines, monoclonal antibodies, means of transporting virus.IFI: Immuno-fluorescence kits ( single test and multitest).Brucellacapt: Diagnosis of Brucellosis.ELISA: Kits for the detection of specific antibodies.

contactPlaza Domínguez Ortiz 1Polígono Industrial 2 de Octubre Santa Fé18320 Granada - Spain

Tel: (+3�) 9� 8�� 12 6�Fax: (+3�) 9� 8�1 07 12http://www.vircell.com

almudena rojasManagerarojas@vircell.com

vidacord Sector: biotechnolgy. cell Therapy

missionTo process and criopreserve the cord blood that parents entrust VidaCord. To offer their children in the future the possibility to use these cells or their derivatives to treat certain diseases.

productsObtaining, processing and criopreserving stem cells from blood cord

interest areas for future collaborationsCell TherapyRegenerative Medicine

contactAdministration: Almagro 38, bajo dcha.28010 Madrid - SpainLaboratory: Edificio Zye Tecnoalcalá Alcalá de Henares - Madrid - Spain

Tel: (+3�) 91 702 68 79Fax: (+3�) 91 702 69 8�http://www.vidacord.es

mónica lópez barahonaGeneral Scientific and Technical Directormlbarahona@vidacord.es

�8

Zona Especial canaria (ZEc) Sector: public administration. consortium between the ministry of economic affairs and finance and the canary islands Government.

missionTo attract investments to the Canary Islands and create employment with the aim of diversifying the production base of the Islands. Biotechnology is a strategic area for the ZEC.

productsThe Canary Islands Special Zone is a low tax zone. The main attraction is the corporate income tax at the rate of �% as opposed to the average Spanish rate of 30%.

interest areas for future collaborationsCompanies interested in being located or opening subsidiaries in the Canary Islands.

contactLeón y Castillo, �31 – �ª planta (Edificio URBIS)3�007 Las Palmas de Gran Canaria

Avenida José Antonio, 3 – �ª planta (Edificio MAPFRE)38003 Santa Cruz de Tenerife

Tel: (+3�) 92 8�9 0� 0�Fax: (+3�) 92 8�9 0� 0�http://www.zec.org

Tel: (+3�) 92 229 80 10Fax: (+3�) 92 227 80 63

José cerezoDirector of External Relationsjmcerezo@zec.org